Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study - Concepedia

Concepedia

Publication | Open Access

Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study

DOI Full Paper Access

49

Citations

36

References

2021

Year

Will J. McLean, Ashley Hinton, Jenna Herby, Alec N. Salt, Jared J. Hartsock, Sam Wilson, David L. Lucchino, Thomas Lenarz, Athanasia Warnecke, Nils Prenzler,

Otology & Neurotology

Abstract

Delivery of FX-322 to the extended high-frequency region of the cochlea is well tolerated and enhances speech recognition performance in multiple subjects with stable chronic hearing loss.

References

	Year	Citations

Page 1